Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT06748118
Recruiting Not applicable

Improving Patients' Adherence to Their Chronic Treatments by Implementing a Simple, Standardized and Redundant Message Delivered by Healthcare Professionals.

NCT06748118 · tracked via the Priya Life Science France tracker
Sponsor
Assistance Publique - Hôpitaux de Paris
Phase
Not applicable
Started
2026-03-18
Last updated
2026-07-01

Condition(s) studied

Chronic DiseaseTherapeutic AdherenceTraining Group, SensitivityDelivery Simple, Standardized & Redundant Message to Patient

Investigational drug(s) / intervention(s)

Trained healthcare professionals deliver a simple, standardized and redundant 3-point message to patients, based on the levers of action for therapeutic adherence.

Trained healthcare professionals deliver a simple, standardized and redundant 3-point message to patients, based on the levers of action for therapeutic adherence.: This message is delivered with the aim of modifying the patient's behavior with regard to treatment intake. The research does not anticipate any change in the patient's medical prescriptions.

Study summary

The primary objective in this study is to achieve a 15% 6-month improvement in therapeutic adherence among patients with chronic pathologies, thanks to a simple, standardized and redundant message delivered by healthcare professionals during consultations/interviews Trained healthcare professionals deliver a simple, standardized and redundant 3-point message to patients, based on the levers of action concerning therapeutic adherence. This message is delivered with the aim of modifying the patient's behavior with regard to treatment intake.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adult patients (age ≥ 18 years) * Affiliated to the French social security system * Followed in hospital for a chronic pathology within a formalized care pathway * Having signed a consent form to participate in the study. Exclusion Criteria: * Patients included in the control period. * Patients under guardianship. * Pregnant or breast-feeding patients. * Patients taking part in research on compliance

Primary outcome measure(s)

Trial sites (10)

FacilityCityRegionStatus
CHU d'Angers Angers France Recruiting
CH d'Antibes Antibes France Recruiting
Hôpital Corentin Celton Issy-les-Moulineaux France Recruiting
Hôpital de la Conception Marseille France Recruiting
Hôpital La Timone Marseille France Recruiting
CHU de Nantes Nantes France Recruiting
Hôpital européen Georges-Pompidou Paris France Recruiting
Hôpital Bicêtre Paris France Recruiting
CHU de Toulouse Toulouse France Recruiting
CHU de Tours Tours France Recruiting

More Assistance Publique - Hôpitaux de Paris trials in France

Molecular Signature From Tumor to Lymph Nodes Recruiting
Efficacy of Two Ultrasound-guided Intra-articular Injections of Botox® Combined With Custom-made Rigid Splinting in Painful Base-of-thumb Osteoarthritis. Recruiting
Impact of Confirmed Autoimmune Encephalitis on Brain Glucose Metabolism Recruiting
Improve MRI Diagnosis Starting soon
Workshops and Exchange Groups for Laryngectomized Patients Recruiting

Other trials for the same condition

Impact of an Intervention Integrating the MPHS Nursing Model of Care on the Partnership in Health, With the Patient Followed in Primary Care by an Advanced Practice Nurse (APN) for One or More Stabilized Chronic Pathologies Recruiting
Impact of Mulstidisciplinary Medication Assessment Review in Surgery Departments Recruiting
Impact of Implementing the Modified A-DIVA Scale on Successful Access to a Venous Line on the First Attempt Recruiting
Glycosylation Analysis of Lupus Anti-DNA Antibodies (GALA) Recruiting
Therapeutic Drug Monitoring-baSed adalimuMab De-escalatiOn in nOn-infecTious cHronic Uveitis Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06748118 on ClinicalTrials.gov ↗ ← All trials in France